Parkinson’s Disease

House of Lords written question – answered on 9th July 2014.

Alert me about debates like this

Photo of Lord Walton of Detchant Lord Walton of Detchant Crossbench

To ask Her Majesty’s Government what advice the Clinical Priorities Advisory Group received about the routine use of Duodopa for advanced Parkinson's disease.

Photo of Earl Howe Earl Howe The Parliamentary Under-Secretary of State for Health

We understand that the Clinical Priorities Advisory Group considered evidence on the clinical effectiveness and estimated costs of Duodopa. NHS England plans to publish a commissioning policy statement for Duodopa in due course.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.